BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37289274)

  • 1. Automatic Detection of Pancreatic Lesions and Main Pancreatic Duct Dilatation on Portal Venous CT Scans Using Deep Learning.
    Abi Nader C; Vetil R; Wood LK; Rohe MM; Bône A; Karteszi H; Vullierme MP
    Invest Radiol; 2023 Nov; 58(11):791-798. PubMed ID: 37289274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of main pancreatic duct cutoff with dilatation, but without visible pancreatic focal lesion on MDCT: a novel diagnostic approach for malignant stricture using a CT-based nomogram.
    Lim CY; Min JH; Hwang JA; Choi SY; Ko SE
    Eur Radiol; 2022 Dec; 32(12):8285-8295. PubMed ID: 35726102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.
    Kang MJ; Jang JY; Lee S; Park T; Lee SY; Kim SW
    World J Surg; 2015 Aug; 39(8):2006-13. PubMed ID: 25894399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery.
    Kim TH; Song TJ; Lee SO; Park CH; Moon JH; Pih GY; Oh DW; Woo SM; Yang YJ; Kim MH
    Pancreatology; 2019 Dec; 19(8):1054-1060. PubMed ID: 31611130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and radiologic characteristics of pancreatic head carcinoma without main pancreatic duct dilatation: using dual-phase contrast-enhanced CT scan.
    Ko SE; Choi IY; Cha SH; Yeom SK; Lee SH; Chung HH; Hyun JJ
    Clin Imaging; 2016; 40(3):548-52. PubMed ID: 27133702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Threshold of main pancreatic duct for malignancy in intraductal papillary mucinous neoplasm at head-neck and body-tail.
    Zhou H; Li X; Wang Y; Wang Z; Zhu J; Wang Z; Chen X
    BMC Gastroenterol; 2022 Nov; 22(1):473. PubMed ID: 36402960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated Main Pancreatic Duct Dilatation: CT Differentiation Between Benign and Malignant Causes.
    Kim SW; Kim SH; Lee DH; Lee SM; Kim YS; Jang JY; Han JK
    AJR Am J Roentgenol; 2017 Nov; 209(5):1046-1055. PubMed ID: 28858540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline.
    Hwang JA; Choi SY; Lee JE; Kim SS; Lee S; Moon JY; Heo NH
    Eur Radiol; 2020 Jul; 30(7):3711-3722. PubMed ID: 32095876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Threshold of Main Pancreatic Duct Diameter in Identifying Malignant Intraductal Papillary Mucinous Neoplasm by Magnetic Resonance Imaging.
    Zhang H; Cao Y; Ren S; Guo K; Zhang Y; Lin T; Wang Y; Chen X; Wang Z
    Technol Cancer Res Treat; 2023; 22():15330338231170942. PubMed ID: 37078135
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Main Duct Thresholds for Malignancy Are Different in Intraductal Papillary Mucinous Neoplasms of the Pancreatic Head and Body-Tail.
    Crippa S; Aleotti F; Longo E; Belfiori G; Partelli S; Tamburrino D; Di Salvo F; De Cobelli F; Romano L; Arcidiacono PG; Petrone MC; Zamboni G; Lena MS; Doglioni C; Falconi M
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):390-399.e7. PubMed ID: 33385536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dilatation of the main pancreatic duct of unknown origin: causes and risk factors of pre-malignancy or malignancy.
    Martin A; Cros J; Vullierme MP; Dokmak S; Sauvanet A; Levy P; Rebours V; Maire F
    Surg Endosc; 2023 May; 37(5):3684-3690. PubMed ID: 36639578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes of Intraductal Papillary Mucinous Neoplasms With Dilatation of the Main Pancreatic Duct.
    Hamada T; Oyama H; Nakai Y; Tange S; Arita J; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kawaguchi Y; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Tanaka M; Tateishi K; Ushiku T; Hasegawa K; Fujishiro M
    Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1792-1801.e3. PubMed ID: 36787835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraductal papillary mucinous tumor of the pancreas: computerized tomography and magnetic resonance imaging features.
    Hong TM; Lee RC; Chiang JH; Chang CY
    Kaohsiung J Med Sci; 2003 Feb; 19(2):55-61. PubMed ID: 12751598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.
    Jang KM; Kim SH; Kim YK; Song KD; Lee SJ; Choi D
    Eur J Radiol; 2015 Aug; 84(8):1473-1479. PubMed ID: 26032128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive Intraductal Papillary Mucinous Neoplasms: CT Features of Colloid Carcinoma Versus Tubular Adenocarcinoma of the Pancreas.
    Fouladi DF; Raman SP; Hruban RH; Fishman EK; Kawamoto S
    AJR Am J Roentgenol; 2020 May; 214(5):1092-1100. PubMed ID: 32130045
    [No Abstract]   [Full Text] [Related]  

  • 17. The natural history of main duct-involved, mixed-type intraductal papillary mucinous neoplasm: parameters predictive of progression.
    Roch AM; Ceppa EP; Al-Haddad MA; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    Ann Surg; 2014 Oct; 260(4):680-8; discussion 688-90. PubMed ID: 25203885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10 mm or less.
    Jung W; Park T; Kim Y; Park H; Han Y; He J; Wolfgang CL; Blair A; Rashid MF; Kluger MD; Su GH; Chabot JA; Yang CY; Lou W; Valente R; Del Chiaro M; Shyr YM; Wang SE; van Huijgevoort NCM; Besselink MG; Yang Y; Kim H; Kwon W; Kim SW; Jang JY
    Br J Surg; 2019 Dec; 106(13):1829-1836. PubMed ID: 31441048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic intraductal papillary mucinous neoplasms: role of CT in predicting pathologic subtypes.
    Gupta R; Mortelé KJ; Tatli S; Girshman J; Glickman JN; Levy AD; Erturk SM; Heffess CS; Banks PA; Silverman SG
    AJR Am J Roentgenol; 2008 Nov; 191(5):1458-64. PubMed ID: 18941085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volumetric and morphological analysis of intraductal papillary mucinous neoplasm of the pancreas using computed tomography and magnetic resonance imaging.
    Murayama S; Kimura W; Hirai I; Takasu N; Takeshita A; Moriya T
    Pancreas; 2011 Aug; 40(6):876-82. PubMed ID: 21747312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.